Thank you, Ben. Fantastic reading.
My major concern is if the Vaxinia / CF33 suite really does disrupt global cancer treatment markets, and threatens to erode the massive existing revenue streams of BP.. how will they respond? Partnering with Imugene is great, but BP certainly don’t have a great ethical record, and Imugene may have to face some untoward tactics from competitors holding on to existing treatment lines.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.13M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.2¢ | 1.1¢ | $241.4K | 21.92M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 9784334 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 12173018 | 54 |
View Market Depth
| Last trade - 14.02pm 26/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |